Triple

T21057569
Position Surface form Disambiguated ID Type / Status
Subject fingolimod E518759 entity
Predicate targetsReceptor P142668 FINISHED
Object S1P3 receptor
The S1P3 receptor is a G protein–coupled sphingosine-1-phosphate receptor involved in regulating vascular tone, immune cell trafficking, and cardiovascular function.
E1465574 NE FINISHED

How this triple was built (4 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: S1P3 receptor | Statement: [fingolimod, targetsReceptor, S1P3 receptor]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07
Target entity: S1P3 receptor
Context triple: [fingolimod, targetsReceptor, S1P3 receptor]
  • A. PLCγ2
    PLCγ2 is a phospholipase C isoform that functions as a key signaling enzyme in immune cells, mediating receptor-induced calcium mobilization and downstream activation pathways.
  • B. CB2 receptor
    The CB2 receptor is a cannabinoid receptor primarily expressed in immune and peripheral tissues, where it modulates inflammation and immune responses and serves as a key target of compounds like THC.
  • C. CCR5
    CCR5 is a human cell-surface chemokine receptor best known as a key co-receptor for HIV entry into immune cells and as a target for both natural resistance and gene-editing interventions against HIV infection.
  • D. CB1 receptor
    The CB1 receptor is a G protein–coupled cannabinoid receptor in the brain and nervous system that mediates most of the psychoactive effects of cannabis.
  • E. CD22
    CD22 is a B-cell–specific surface glycoprotein that functions as an inhibitory co-receptor modulating B cell receptor signaling and immune responses.
  • F. None of above. chosen
  • G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg Description generation gpt-5.1
Instruction
Generate a one-sentence description of the target entity. 
You are given a context triple in the form (subject, predicate, object), where the object is the target entity. 
# Instructions
Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. 
Avoid repeating the information from the triple, unless really essential.
# Response Format
Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: S1P3 receptor
Triple: [fingolimod, targetsReceptor, S1P3 receptor]
Generated description
The S1P3 receptor is a G protein–coupled sphingosine-1-phosphate receptor involved in regulating vascular tone, immune cell trafficking, and cardiovascular function.
NED2 Entity disambiguation (via description) gpt-5-mini-2025-08-07
Target entity: S1P3 receptor
Target entity description: The S1P3 receptor is a G protein–coupled sphingosine-1-phosphate receptor involved in regulating vascular tone, immune cell trafficking, and cardiovascular function.
  • A. PLCγ2
    PLCγ2 is a phospholipase C isoform that functions as a key signaling enzyme in immune cells, mediating receptor-induced calcium mobilization and downstream activation pathways.
  • B. CB2 receptor
    The CB2 receptor is a cannabinoid receptor primarily expressed in immune and peripheral tissues, where it modulates inflammation and immune responses and serves as a key target of compounds like THC.
  • C. CCR5
    CCR5 is a human cell-surface chemokine receptor best known as a key co-receptor for HIV entry into immune cells and as a target for both natural resistance and gene-editing interventions against HIV infection.
  • D. CB1 receptor
    The CB1 receptor is a G protein–coupled cannabinoid receptor in the brain and nervous system that mediates most of the psychoactive effects of cannabis.
  • E. CD22
    CD22 is a B-cell–specific surface glycoprotein that functions as an inhibitory co-receptor modulating B cell receptor signaling and immune responses.
  • F. None of above. chosen

Provenance (5 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69e0b5053ac48190921529544959e906 completed April 16, 2026, 10:08 a.m.
NER Named-entity recognition batch_69e6fd81434c8190aedfddf937f82322 completed April 21, 2026, 4:30 a.m.
NED1 Entity disambiguation (via context triple) batch_6a09506aebb081908729fbbdd50009a8 completed May 17, 2026, 5:21 a.m.
NEDg Description generation batch_6a0954419f2c81909d2bf51a9d41b740 completed May 17, 2026, 5:38 a.m.
NED2 Entity disambiguation (via description) batch_6a09549f13748190bf8daa3c3cb3301c completed May 17, 2026, 5:39 a.m.
Created at: April 16, 2026, 2:37 p.m.